GLAS
Glass House Brands Inc.
Drug Manufacturers - Specialty & Generic · Healthcare · United States
9.97
close · 2026-08-13
value
8
cheaper than peers8
quality
17
stronger fundamentals17
ranked against
Drug Manufacturers - Specialty & Generic
value
quality
34 peerswide variation
Value inputs
| measure | company | vs peers |
| price to sales | 4.75× | 24 |
| price to book | 10.98× | 22 |
| forward P/E | 37.62× | 6 |
3 of 12 measures available
Quality inputs
| measure | company | vs peers |
| debt to equity | 42.3% | 81 |
| return on equity | -20.4% | 27 |
| revenue growth | -9.6% | 17 |
| operating margin | -35.4% | 10 |
4 of 4 measures available
Facts
| market cap | $894M |
| free cash flow | -$26.1M |
| employees | 357 |
| first trade | 2019-07-18 |
| next earnings | 2026-08-13 |
| fundamentals updated | 2026-07-29 |